Augmentation of depressed Lymphokine Activated Killer activity by continuous intravenous-administration of Recombinant Interleukin 2 to patients with Hepatocellular carcinoma
- 1 January 1987
- journal article
- Published by Japan Society for Clinical Immunology in Japanese Journal of Clinical Immunology
- Vol. 10 (2) , 201-206
- https://doi.org/10.2177/jsci.10.201
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: